Mico BioMed wins $2.6M COVID-19 diagnostic order from Argentina

Mico BioMed received a large order from Argentina for 180 molecular diagnostic devices and 2.6 million test kits, valued at $2.6 million. Initial delivery of 60 devices and 100,000 test kits is scheduled for late October to early November 2020, with the remainder to be delivered by 2022.

“이번 아르헨티나 납품 건은 당사 최대 매출처인 브라질에 이은 또 다른 중남미 국가를 주요 고객으로 확보했다는데 그 의미가 있다”the-stock.kr

• 1 source
• the-stock.kr미코바이오메드, 아르헨티나서 코로나19 분자진단제품 대규모 수주 < Issue < 기사본문 - 더스탁(The Stock)민현기 기자Oct 15, 2020

Summarized from public sources; check the original articles before acting on it.